Improvement in Thyroid Function in Hashimoto's Thyroiditis

Pathophysiological Mechanisms of Improvement

Hashimoto's thyroiditis is an autoimmune disorder characterized by lymphocyte infiltration of the thyroid gland and elevated antibodies against thyroid peroxidase and thyroglobulin 1, 2
Spontaneous normalization of thyroid function can occur in patients with mild TSH elevations, with 30-60% of high TSH levels normalizing on repeat testing after 3-6 weeks 3

Levothyroxine (T4) therapy is the principal treatment for hypothyroidism in Hashimoto's thyroiditis and can lead to significant improvement in thyroid function 2

TSH is the primary screening test for thyroid dysfunction, with multiple tests recommended over a 3-6 month interval to confirm improvement 2
For patients on levothyroxine therapy, TSH should be monitored every 6-8 weeks while titrating hormone replacement, with a goal of achieving TSH within the reference range 3
Free T4 can help interpret ongoing abnormal TSH levels during therapy, as TSH may take longer to normalize 4
Once adequately treated, repeat testing should be done every 6-12 months or if symptoms change 4

Development of a low TSH on therapy suggests overtreatment or recovery of thyroid function, and dose should be reduced or discontinued with close follow-up 4
Overtreatment with levothyroxine can lead to iatrogenic hyperthyroidism, increasing the risk for osteoporosis, fractures, abnormal cardiac output, and ventricular hypertrophy 3
Failure to recognize transient hypothyroidism may lead to unnecessary lifelong treatment, highlighting the importance of careful diagnosis and monitoring 3
About 1 in 4 patients receiving levothyroxine are maintained unintentionally on doses sufficient to fully suppress TSH, which may increase the risk of adverse effects such as atrial fibrillation 5

For patients over 70 years or with cardiac disease/multiple comorbidities, starting with a lower dose of levothyroxine (25-50 mcg/day) and titrating gradually is recommended to avoid adverse effects 4
For women planning pregnancy, treatment of subclinical hypothyroidism is particularly important as it may be associated with adverse pregnancy outcomes, and levothyroxine requirements often increase during pregnancy 3